Allozymes
Singapore
About Allozymes
Allozymes is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We develop sensitive, accurate, and generic assays to detect enzymatic reactions, proprietary microfluidic chips, and proteomics technologies to take enzyme development to the next level.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2023)
- Website: allozymes.com
- Phone: [email protected]
Industries & Categories
B2B, Biotechnology, Health Care, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/allozymes-87376 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.